NCT00280969View on ClinicalTrials.gov

Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment

PHASE3CompletedINTERVENTIONAL
Enrollment

71

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions
HIV Infection
Interventions
DRUG

atazanavir arm

Patients are treated with ritonavir 100mg boosted atazanavir 300mg along with Epzicom.

DRUG

efavirenz

Patients are treated with efavirenz 300mg along with Epzicom.

Trial Locations (1)

162-8655

International Medical Center of Japan, Shinjuku

Sponsors
All Listed Sponsors
collaborator

Ministry of Health, Labour and Welfare, Japan

OTHER_GOV

lead

International Medical Center of Japan

OTHER_GOV